Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Schmidt

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Behavioural Brain Research|July 22, 2004
L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated ratsM Alam, W J Schmidt
Physiology & Behavior|December 8, 2004
Mitochondrial complex I inhibition depletes plasma testosterone in the rotenone model of Parkinson's diseaseM Alam, W J Schmidt
Neurotoxicity Research|November 17, 2004
Immediate early gene expression in rat basal ganglia after destruction of the dopaminergic systemV Pedersen, W J Schmidt
Neuroscience Letters|August 30, 2003
Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in ratsU Kratzer, W J Schmidt
Physiology & Behavior|July 1, 1980
Antidepressants and the control of predatory behaviorW J Schmidt, G Meierl
Behavioural Pharmacology|June 9, 2001
NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependentA Lanis, W J Schmidt
Behavioural Brain Research|March 1, 1995
Low-dose challenge by the NMDA receptor antagonist dizocilpine exacerbates the spatial learning deficit in entorhinal cortex-lesioned ratsU Keseberg, W J Schmidt
Behavioural Brain Research|March 5, 1990
6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial mazeM Bubser, W J Schmidt
Behavioural Processes|June 14, 2014
Effects of systemically and intrastriatally injected haloperidol and apomorphine on grooming, feeding and locomotion in the ratD Bury, W J Schmidt
European Journal of Pharmacology|March 23, 1993
The sigma receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophreniaN G Rückert, W J Schmidt
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Behavioural Brain Research|July 22, 2004
L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated ratsM Alam, W J Schmidt
Physiology & Behavior|December 8, 2004
Mitochondrial complex I inhibition depletes plasma testosterone in the rotenone model of Parkinson's diseaseM Alam, W J Schmidt
Neurotoxicity Research|November 17, 2004
Immediate early gene expression in rat basal ganglia after destruction of the dopaminergic systemV Pedersen, W J Schmidt
Neuroscience Letters|August 30, 2003
Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in ratsU Kratzer, W J Schmidt
Physiology & Behavior|July 1, 1980
Antidepressants and the control of predatory behaviorW J Schmidt, G Meierl
Behavioural Pharmacology|June 9, 2001
NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependentA Lanis, W J Schmidt
Behavioural Brain Research|March 1, 1995
Low-dose challenge by the NMDA receptor antagonist dizocilpine exacerbates the spatial learning deficit in entorhinal cortex-lesioned ratsU Keseberg, W J Schmidt
Behavioural Brain Research|March 5, 1990
6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial mazeM Bubser, W J Schmidt
Behavioural Processes|June 14, 2014
Effects of systemically and intrastriatally injected haloperidol and apomorphine on grooming, feeding and locomotion in the ratD Bury, W J Schmidt
European Journal of Pharmacology|March 23, 1993
The sigma receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophreniaN G Rückert, W J Schmidt
Pageof 13